Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Perfluoropentane is a very hydrophobic, chemically inert, nontoxic, and noncarcinogenic fluorinated hydrocarbon with the molecular formula C5F12 and a boiling point near room temperature. It is not a biological macromolecule, enzyme, receptor, or traditional therapeutic target. Instead, it is used as a **radioopaque medium** and **ultrasound contrast agent** in medicine—most prominently as a component in microbubble contrast agents for ultrasound imaging and in occlusion therapies, where its propensity for phase transition under ultrasound (acoustic droplet vaporization) is exploited for controlling microbubble formation. It is not known to interact with typical drugs or play a biological signaling role, and should not be listed as a molecular therapeutic target. Alternate uses include propellants for inhalers and various diagnostic aids. Perfluoropentane is commonly included in drug and biomedical device formulations but is best described as a physical agent or excipient, not a molecular target. If entered as a "target" for drug interaction or biological pathway mapping, this is a category error.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Perfluoropentane (PFP).